Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Ro vs Semaglutide Online

Two GLP-1 desks, one scoreboard. We put Ro and Semaglutide Online head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 13 · Grade B+

Ro

Visit Ro Full brief →
vs
No. 35 · Grade B

Semaglutide Online

Visit Semaglutide Online Full brief →

The verdict

Ro takes this head-to-head.

Ro scores 87 to 83 on our six-factor Brief Score — A heavyweight platform with brand-name access and a polished experience — but it keeps compounded pricing off the record.

That doesn't make Semaglutide Online a bad call — it's best for readers who want legitscript glp-1 nationwide ex. al; compounded sema $199 or tirz $299/mo all-in; financing from $79/mo. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
80
78
Supply Reliability
90
77
Transparency
80
88
Access Breadth
92
97
Clinical Oversight
90
81
Track Record
89
78
RoBrief Score 87 · 83Semaglutide Online

Price, coverage & the tracker

RoSemaglutide Online
Brief Score87/100 (B+)83/100 (B)
SemaglutideNot disclosedFrom $199/mo (all doses, compounded)
TirzepatideNot disclosedFrom $299/mo (all doses, compounded)
CoverageMulti-stateAll 50 states
Brand-name accessYesYes
Oral / sublingualYesYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

Ro: Brand-name access and insurance navigation, but compounded pricing stays off the record.

Semaglutide Online: New to the tracker on 1 August 2026. The published line reads From $199/mo (all doses, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.